These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 9523749

  • 1. Clinical experience with anti-D in the treatment of idiopathic thrombocytopenic purpura.
    Scaradavou A, Bussel JB.
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):52-7. PubMed ID: 9523749
    [Abstract] [Full Text] [Related]

  • 2. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F.
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [Abstract] [Full Text] [Related]

  • 3. Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura.
    Moser AM, Shalev H, Kapelushnik J.
    Pediatr Hematol Oncol; 2002 Sep; 19(6):407-11. PubMed ID: 12186363
    [Abstract] [Full Text] [Related]

  • 4. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children.
    Freiberg A, Mauger D.
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746
    [Abstract] [Full Text] [Related]

  • 5. Idiopathic thrombocytopenic purpura diagnosed during the second decade of life.
    Lowe EJ, Buchanan GR.
    J Pediatr; 2002 Aug; 141(2):253-8. PubMed ID: 12183723
    [Abstract] [Full Text] [Related]

  • 6. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS, Mokhtar GM, El-Laboudy MA, Khalifa AS.
    Acta Haematol; 2006 Aug; 115(1-2):46-52. PubMed ID: 16424649
    [Abstract] [Full Text] [Related]

  • 7. Management of adult idiopathic thrombocytopenic purpura.
    Nakhoul IN, Kozuch P, Varma M.
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
    [Abstract] [Full Text] [Related]

  • 8. Management of chronic immune thrombocytopenic purpura in children and adults.
    Blanchette V, Freedman J, Garvey B.
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):36-51. PubMed ID: 9523748
    [Abstract] [Full Text] [Related]

  • 9. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
    Kumar M, Vik TA, Johnson CS, Southwood ME, Croop JM.
    Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
    [Abstract] [Full Text] [Related]

  • 10. Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy?
    Bussel JB, Kaufmann CP, Ware RE, Woloski BM.
    Am J Hematol; 2001 May; 67(1):27-33. PubMed ID: 11279654
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the effects of and earliest response rate to anti-D treatment in children with chronic idiopathic thrombocytopenic purpura: a pilot study.
    Yetgin S, Aytaç S, Olcay L, Tunç B, Ozbek N, Aydinok Y.
    Turk J Pediatr; 2010 May; 52(2):126-31. PubMed ID: 20560246
    [Abstract] [Full Text] [Related]

  • 12. Treatment of acute immune thrombocytopenic purpura.
    Tarantino MD, Goldsmith G.
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
    [Abstract] [Full Text] [Related]

  • 13. Idiopathic thrombocytopenia purpura: Treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy.
    Simpson KN, Coughlin CM, Eron J, Bussel JB.
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):58-64. PubMed ID: 9523750
    [Abstract] [Full Text] [Related]

  • 14. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.
    Tarantino MD, Young G, Bertolone SJ, Kalinyak KA, Shafer FE, Kulkarni R, Weber LC, Davis ML, Lynn H, Nugent DJ, Acute ITP Study Group.
    J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411
    [Abstract] [Full Text] [Related]

  • 15. Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura.
    Kane I, Ragucci D, Shatat IF, Bussel J, Kalpatthi R.
    Br J Haematol; 2010 Apr; 149(1):79-83. PubMed ID: 20096011
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura.
    Ramadan KM, El-Agnaf M.
    Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495
    [Abstract] [Full Text] [Related]

  • 17. Does intravenous immune globulin have a role in HIV-infected patients?
    Yap PL.
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):59-67. PubMed ID: 8033437
    [Abstract] [Full Text] [Related]

  • 18. Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura.
    Chun NS, Savani B, Seder RH, Taplin ME.
    Am J Hematol; 2003 Dec; 74(4):276-9. PubMed ID: 14635210
    [Abstract] [Full Text] [Related]

  • 19. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG.
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [Abstract] [Full Text] [Related]

  • 20. Treatment of immune thrombocytopenic purpura in adults.
    Bussel J.
    Semin Hematol; 2006 Jul; 43(3 Suppl 5):S3-10; discussion S18-9. PubMed ID: 16815346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.